Indication
Chronic hepatitis C - genotype 4
Chronic hepatitis C – genotype 4 is a persistent hepatic infection lasting longer than six months caused by genotype 4 of the hepatitis C virus (HCV), an enveloped positive-sense single-stranded RNA virus. Read more about Chronic hepatitis C - genotype 4
31 drugs 13 manufacturers
Drugs that treat it
Common Chronic hepatitis C - genotype 4 therapies.
SOFOSBUVIR-VELPATASVIR (sofosbuvir/velpatasvir)
PEGASYS (peginterferon alfa-2a)
PEGASYS (peginterferon alfa-2a)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonChronic hepatitis C – genotype 4 is a persistent hepatic infection lasting longer than six months caused by genotype 4 of the hepatitis C virus (HCV), an enveloped positive-sense single-stranded RNA virus.
Predominantly affecting the liver across adult and pediatric populations—historically most prevalent in North Africa and the Middle East—this viral subtype induces chronic necroinflammation of hepatocytes and immune-mediated tissue injury.
While the infection is often clinically silent for years, ongoing viral persistence promotes progressive hepatic fibrosis, which can advance to cirrhosis, end-stage liver disease, portal hypertension, and hepatocellular carcinoma.
The genotype 4 classification specifically denotes a distinct viral genomic lineage defined by molecular diagnostics, which has historically informed antiviral drug responsiveness and regimen selection.
- cdc.gov
Chronic hepatitis C – genotype 4 is a persistent hepatic infection lasting longer than six months caused by genotype 4 of the hepatitis C virus (HCV), an enveloped positive-sense single-stranded RNA virus While the infection is often clinically silent for years, ongoing viral persistence promotes progressive hepatic fibrosis, which can advance to cirrhosis, end-stage liver disease, portal hypertension, and hepatocellular carcinoma
- nih.gov
Chronic hepatitis C – genotype 4 is a persistent hepatic infection lasting longer than six months caused by genotype 4 of the hepatitis C virus (HCV), an enveloped positive-sense single-stranded RNA virus Predominantly affecting the liver across adult and pediatric populations—historically most prevalent in North Africa and the Middle East—this viral subtype induces chronic necroinflammation of hepatocytes and immune-mediated tissue injury
- aasld.org
Predominantly affecting the liver across adult and pediatric populations—historically most prevalent in North Africa and the Middle East—this viral subtype induces chronic necroinflammation of hepatocytes and immune-mediated tissue injury
- nih.gov
While the infection is often clinically silent for years, ongoing viral persistence promotes progressive hepatic fibrosis, which can advance to cirrhosis, end-stage liver disease, portal hypertension, and hepatocellular carcinoma
- nih.gov
The genotype 4 classification specifically denotes a distinct viral genomic lineage defined by molecular diagnostics, which has historically informed antiviral drug responsiveness and regimen selection
- aasld.org
The genotype 4 classification specifically denotes a distinct viral genomic lineage defined by molecular diagnostics, which has historically informed antiviral drug responsiveness and regimen selection
- va.gov
The genotype 4 classification specifically denotes a distinct viral genomic lineage defined by molecular diagnostics, which has historically informed antiviral drug responsiveness and regimen selection
Personalize your experience
Follow Chronic hepatitis C - genotype 4 and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.